Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
The current role of mitoxantrone in the treatment of multiple sclerosis.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Whole brain myelin mapping using T1- and T2-weighted MR imaging data.
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
Pediatric demyelinating diseases.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Neurology in the developing world.
Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
[Immunotherapies for multiple sclerosis : Review and update.]
Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
Interpretation of magnetization transfer from inhomogeneously broadened lines (ihMT) in tissues as a dipolar order effect within motion restricted molecules.
Construction and validation of the chronic acquired polyneuropathy patient-reported index, "CAP-PRI:" a disease-specific, health-related quality of life instrument.
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.

Pages